THOUGHTSPOT Wearable vs. Home-Based Medical Alert Systems: Which Is Best for Seniors?ByEvans JamesJanuary 15, 20250Comments
INSIGHTS+ J.P. Morgan Special: Dealmaker of the Year 2024 (Part 02)ByPrince GiriJanuary 15, 20250Comments
News Eli Lilly Inks ~2.5B Deal to Acquire Scorpion TherapeuticsByDipanshu DixitJanuary 14, 20250Comments
News The US FDA grants 510(k) Clearance to Werfen’s Aptiva Antiphospholipid Syndrome (APS) ReagentsByDipanshu DixitJanuary 14, 20250Comments
News Teva Partners with Klinge Biopharma & Formycon to Commercialize FYB203 (Biosimilar: Aflibercept) in EU & IsraelByDipanshu DixitJanuary 14, 20250Comments
News The US FDA Grants Fast Track Designation to BridgeBio Oncology Therapeutics’ BBO-8520 for KRASG12C-Mutated Metastatic Non-Small Cell Lung CancerByDipanshu DixitJanuary 14, 20250Comments
News Oryzon Reports Dosing of the First Patient with Iadademstat + Venetoclax + Azacitidine in P-I Trial to Treat 1L Acute Myeloid Leukemia (AML)ByDipanshu DixitJanuary 14, 20250Comments
News Johnson & Johnson to Acquire Intra-Cellular Therapies for ~14.6B, Boosting its Neuroscience PortfolioByDipanshu DixitJanuary 14, 20250Comments
News Neurocrine’s Crenessity (Crinecerfont) Secures the US FDA’s Approval to Treat Adults and Pediatrics with Congenital Adrenal Hyperplasia (CAH)ByDipanshu DixitJanuary 14, 20250Comments
